InMed Pharmaceuticals Inc. (NASDAQ: INM) reported Q1 EPS of ($2.17). Revenue for the quarter came in at $1.26 million.

For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (INM) click here.